Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cardiff Oncology, Inc. | 2,968,115 | reported | 11 Nov 2016 | tx 4+884,444−322,472 |
| RESPONSE GENETICS INC | 2,604,000 | reported | 11 Nov 2015 | tx 2−90,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Nov 2016 | PURCHASE | Cardiff Oncology, Inc. | 322,472 | 3.08 USD | first after silence |
| 10 Nov 2015 | OTHER | RESPONSE GENETICS INC | 60,000 | 0.00 USD | |
| 11 Nov 2015 | OTHER | RESPONSE GENETICS INC | 30,000 | 0.00 USD | |
| 17 Jul 2015 | PURCHASE | Cardiff Oncology, Inc. | 140,000 | 8.75 USD | |
| 02 Apr 2015 | PURCHASE | Cardiff Oncology, Inc. | 300,000 | 6.90 USD | |
| 06 Feb 2015 | PURCHASE | Cardiff Oncology, Inc. | 444,444 | 4.50 USD |
1 purchase reported after at least 12 months of silence — most recent on 11 Nov 2016.